The level of ApoE in the serum of patients with ovarian cancer was dramatically increased over healthy individuals, and as a marker, it could enhance the specificity and sensitivity of ovarian cancer diagnosis [50]. This evidence concerns the gene APOE and ovarian carcinoma.